Ehsan Mostafavi highlighted the need for the development of health diplomacy, and considered this move as a successful example of health-based international interactions that can be recognized as a model for expanding Iran’s scientific and technological impacts in the international field.
He stressed that this export volume is the largest export of Iran’s Pasteur Institute in recent decades.
The BCG vaccine used to prevent tuberculosis has been continuously produced at the Pasteur Institute in Iran since 1947 and is considered one of the Institute’s strategic products, observing the requirements of international standards.
Referring to the institute’s future plans to expand its vaccine export portfolio, the head of Iran’s Pasteur Institute, noted, “We are currently seeking to develop diversity in vaccines and export products overseas by identifying international capabilities and health needs in various countries.”
As one of the nation’s oldest and most prestigious scientific and health centres, Iran’s Pasteur Institute has played an important role in controlling and preventing infectious diseases in Iran and the region.
Bacillus calmette-guerin (BCG) is a live-fluid vaccine form of Mycobacterium Bovis, which is used to prevent tuberculosis and other mycobacterial infections.
MA/6462395